Therapeutic analysis of cannabidiol for Alzheimer treatment
Autor(a) principal: | |
---|---|
Data de Publicação: | 2024 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/45006 |
Resumo: | Objective: To analyze therapeutic evidence regarding the potential antioxidant, anti-inflammatory and neuroprotective effects of cannabidiol (CBD) and its effectiveness for the treatment of Alzheimer's Disease (AD). Methodology: Data collection, in the Virtual Health Library, targeting the primary databases Medical Literature Analysis and Retrieval System Online (Medline) and Latin American and Caribbean Literature in Health Sciences (Lilacs) to answer the research question: is the therapeutic use of cannabidiol effective in improving the treatment of patients with Alzheimer's Disease? Results: 14 articles were selected, after analyzing the inclusion and exclusion criteria, all after 2017, with the largest number concentrating on systematic literature review or meta-analysis. Conclusion: Cannabidiol has clear potential to reduce the symptoms of AD given its action on the Central Nervous System. Therefore, its therapeutic use in the treatment of AD emerges as a promising field of investigation, highlighting its relevance as a safe and effective treatment option. Therefore, an in-depth understanding of the antioxidant, anti-inflammatory and neuroprotective properties of CBD is necessary, not only for a better clinical definition of AD, but also for a series of neurological diseases that still have undefined treatments. The potential of CBD, therefore, represents a valuable alternative in the context of neurology, offering significant perspectives for the treatment of neurodegenerative conditions. |
id |
UNIFEI_453d2adb4f9f95c7a8c607b9c6350519 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/45006 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Therapeutic analysis of cannabidiol for Alzheimer treatmentAnálisis terapéutico del cannabidiol para el tratamiento de AlzheimerAnálise terapêutica do canabidiol para o tratamento de AlzheimerEnfermedad de AlzheimerTerapéuticoCannabidiolTratamiento.Alzheimer diseaseTherapeuticCannabidiolTreatment.Doença de AlzheimerTerapêuticoCanabidiolTratamento.Objective: To analyze therapeutic evidence regarding the potential antioxidant, anti-inflammatory and neuroprotective effects of cannabidiol (CBD) and its effectiveness for the treatment of Alzheimer's Disease (AD). Methodology: Data collection, in the Virtual Health Library, targeting the primary databases Medical Literature Analysis and Retrieval System Online (Medline) and Latin American and Caribbean Literature in Health Sciences (Lilacs) to answer the research question: is the therapeutic use of cannabidiol effective in improving the treatment of patients with Alzheimer's Disease? Results: 14 articles were selected, after analyzing the inclusion and exclusion criteria, all after 2017, with the largest number concentrating on systematic literature review or meta-analysis. Conclusion: Cannabidiol has clear potential to reduce the symptoms of AD given its action on the Central Nervous System. Therefore, its therapeutic use in the treatment of AD emerges as a promising field of investigation, highlighting its relevance as a safe and effective treatment option. Therefore, an in-depth understanding of the antioxidant, anti-inflammatory and neuroprotective properties of CBD is necessary, not only for a better clinical definition of AD, but also for a series of neurological diseases that still have undefined treatments. The potential of CBD, therefore, represents a valuable alternative in the context of neurology, offering significant perspectives for the treatment of neurodegenerative conditions.Objetivo: Analizar la evidencia terapéutica sobre los potenciales efectos antioxidantes, antiinflamatorios y neuroprotectores del cannabidiol (CBD) y su efectividad para el tratamiento de la Enfermedad de Alzheimer (EA). Metodología: Recolección de datos, en la Biblioteca Virtual en Salud, dirigidos a las bases de datos primarias Medical Literature Analysis and Retrieval System Online (Medline) y Literatura Latinoamericana y del Caribe en Ciencias de la Salud (Lilacs) para responder a la pregunta de investigación: ¿es efectivo el uso terapéutico del cannabidiol para mejorar el tratamiento de pacientes con Enfermedad de Alzheimer? Resultados: Se seleccionaron 14 artículos, luego de analizar los criterios de inclusión y exclusión, todos posteriores a 2017, concentrándose el mayor número en revisión sistemática de literatura o metanálisis. Conclusión: El cannabidiol tiene un claro potencial para reducir los síntomas de la EA dada su acción sobre el Sistema Nervioso Central. Por tanto, su uso terapéutico en el tratamiento de la EA emerge como un campo de investigación prometedor, destacando su relevancia como una opción de tratamiento segura y eficaz. Por tanto, es necesario un conocimiento profundo de las propiedades antioxidantes, antiinflamatorias y neuroprotectoras del CBD, no sólo para una mejor definición clínica de la EA, sino también de una serie de enfermedades neurológicas que aún tienen tratamientos indefinidos. El potencial del CBD, por tanto, representa una alternativa valiosa en el contexto de la neurología, ofreciendo importantes perspectivas para el tratamiento de enfermedades neurodegenerativas.Objetivo: Analisar as evidências terapêuticas quanto aos potenciais efeitos antioxidantes, anti-inflamatórios e neuroprotetores do canabidiol (CDB) e sua eficácia para o tratamento da Doença de Alzheimer (DA). Metodologia: Levantamento de dados, na Biblioteca Virtual em Saúde, com direcionamento às bases primárias Medical Literature Analysis and Retrieval System Online (Medline) e Literatura Latino-Americana e do Caribe em Ciências da Saúde (Lilacs) para responder à pergunta de pesquisa: o uso terapêutico do canabidiol é eficaz para melhorar o tratamento de pacientes com Doença de Alzheimer? Resultados: Foram selecionados 14 artigos, após análise dos critérios de inclusão e exclusão, todos posteriores ao ano de 2017, concentrando-se o maior número em revisão sistemática da literatura ou metanálise. Conclusão: O canabidiol possui potencial evidente para diminuir a sintomatologia da DA tendo em vista sua atuação no Sistema Nervoso Central. Desta forma, seu uso terapêutico no tratamento de DA emerge como um campo de investigação promissor, destacando sua relevância como uma opção de tratamento seguro e efetivo. Portanto, faz-se necessária a compreensão aprofundada das propriedades antioxidantes, anti-inflamatórias e neuroprotetoras do CBD, não apenas para a melhor definição clínica da DA, mas também para uma série de doenças neurológicas que ainda possuem tratamentos indefinidos. O potencial do CBD, assim, representa uma valiosa alternativa no contexto da neurologia, oferecendo perspectivas significativas para o tratamento de condições neurodegenerativas.Research, Society and Development2024-02-17info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/4500610.33448/rsd-v13i2.45006Research, Society and Development; Vol. 13 No. 2; e6513245006Research, Society and Development; Vol. 13 Núm. 2; e6513245006Research, Society and Development; v. 13 n. 2; e65132450062525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIenghttps://rsdjournal.org/index.php/rsd/article/view/45006/35947Copyright (c) 2024 Maria Vitória Frota Magalhães; Ruymara Candal Nogueira ; Joana Baschung Bertazzon; Andressa Gonçalves Vicente; Marcos Gabriel Bastos Sereno; Carlos Vinícius Teixeira Palhares; Marina Rodrigues e Silvahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessMagalhães, Maria Vitória Frota Nogueira , Ruymara Candal Bertazzon, Joana Baschung Vicente, Andressa Gonçalves Sereno, Marcos Gabriel Bastos Palhares, Carlos Vinícius Teixeira Silva, Marina Rodrigues e 2024-03-04T09:47:20Zoai:ojs.pkp.sfu.ca:article/45006Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-03-04T09:47:20Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Therapeutic analysis of cannabidiol for Alzheimer treatment Análisis terapéutico del cannabidiol para el tratamiento de Alzheimer Análise terapêutica do canabidiol para o tratamento de Alzheimer |
title |
Therapeutic analysis of cannabidiol for Alzheimer treatment |
spellingShingle |
Therapeutic analysis of cannabidiol for Alzheimer treatment Magalhães, Maria Vitória Frota Enfermedad de Alzheimer Terapéutico Cannabidiol Tratamiento. Alzheimer disease Therapeutic Cannabidiol Treatment. Doença de Alzheimer Terapêutico Canabidiol Tratamento. |
title_short |
Therapeutic analysis of cannabidiol for Alzheimer treatment |
title_full |
Therapeutic analysis of cannabidiol for Alzheimer treatment |
title_fullStr |
Therapeutic analysis of cannabidiol for Alzheimer treatment |
title_full_unstemmed |
Therapeutic analysis of cannabidiol for Alzheimer treatment |
title_sort |
Therapeutic analysis of cannabidiol for Alzheimer treatment |
author |
Magalhães, Maria Vitória Frota |
author_facet |
Magalhães, Maria Vitória Frota Nogueira , Ruymara Candal Bertazzon, Joana Baschung Vicente, Andressa Gonçalves Sereno, Marcos Gabriel Bastos Palhares, Carlos Vinícius Teixeira Silva, Marina Rodrigues e |
author_role |
author |
author2 |
Nogueira , Ruymara Candal Bertazzon, Joana Baschung Vicente, Andressa Gonçalves Sereno, Marcos Gabriel Bastos Palhares, Carlos Vinícius Teixeira Silva, Marina Rodrigues e |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Magalhães, Maria Vitória Frota Nogueira , Ruymara Candal Bertazzon, Joana Baschung Vicente, Andressa Gonçalves Sereno, Marcos Gabriel Bastos Palhares, Carlos Vinícius Teixeira Silva, Marina Rodrigues e |
dc.subject.por.fl_str_mv |
Enfermedad de Alzheimer Terapéutico Cannabidiol Tratamiento. Alzheimer disease Therapeutic Cannabidiol Treatment. Doença de Alzheimer Terapêutico Canabidiol Tratamento. |
topic |
Enfermedad de Alzheimer Terapéutico Cannabidiol Tratamiento. Alzheimer disease Therapeutic Cannabidiol Treatment. Doença de Alzheimer Terapêutico Canabidiol Tratamento. |
description |
Objective: To analyze therapeutic evidence regarding the potential antioxidant, anti-inflammatory and neuroprotective effects of cannabidiol (CBD) and its effectiveness for the treatment of Alzheimer's Disease (AD). Methodology: Data collection, in the Virtual Health Library, targeting the primary databases Medical Literature Analysis and Retrieval System Online (Medline) and Latin American and Caribbean Literature in Health Sciences (Lilacs) to answer the research question: is the therapeutic use of cannabidiol effective in improving the treatment of patients with Alzheimer's Disease? Results: 14 articles were selected, after analyzing the inclusion and exclusion criteria, all after 2017, with the largest number concentrating on systematic literature review or meta-analysis. Conclusion: Cannabidiol has clear potential to reduce the symptoms of AD given its action on the Central Nervous System. Therefore, its therapeutic use in the treatment of AD emerges as a promising field of investigation, highlighting its relevance as a safe and effective treatment option. Therefore, an in-depth understanding of the antioxidant, anti-inflammatory and neuroprotective properties of CBD is necessary, not only for a better clinical definition of AD, but also for a series of neurological diseases that still have undefined treatments. The potential of CBD, therefore, represents a valuable alternative in the context of neurology, offering significant perspectives for the treatment of neurodegenerative conditions. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-02-17 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/45006 10.33448/rsd-v13i2.45006 |
url |
https://rsdjournal.org/index.php/rsd/article/view/45006 |
identifier_str_mv |
10.33448/rsd-v13i2.45006 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/45006/35947 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 13 No. 2; e6513245006 Research, Society and Development; Vol. 13 Núm. 2; e6513245006 Research, Society and Development; v. 13 n. 2; e6513245006 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052638104125440 |